Jiangsu Hengrui Pharmaceuticals(01276): HRS-7156 tablets received a notice of approval for clinical drug trials.
Hengrui Medicine (01276) announced that recently, its subsidiary Shandong Shengdi Pharmaceutical Co., Ltd. received the approval and issuance of the "Drug Clinical Trial Approval Notice" for HRS-7156 tablets from the National Medical Products Administration (NMPA), and will soon conduct clinical trials.
Jiangsu Hengrui Pharmaceuticals (01276) announced that its subsidiary Shandong Shengdi Pharmaceuticals Co., Ltd. recently received the Drug Clinical Trial Approval Notice issued by the National Drug Administration on HRS-7156 tablets, and will soon start clinical trials.
HRS-7156 tablets are a new type of drug independently developed by the company. Preclinical data shows that HRS-7156 can significantly improve cardiac function and lesions. According to the company's research, there is currently no similar approved medication on the market in China or abroad. As of now, the total research and development investment in the HRS-7156 tablet project is approximately 37.6 million yuan (unaudited).
Related Articles
Touyun Biotech (01332) has signed a strategic cooperation agreement with Shenzhen University to jointly develop the Chlorella Growth Factor project.
YIDA CHINA (03639) The contract sales amount in the first three months was approximately 0.37 billion yuan, a year-on-year decrease of 78.5%
Preview of US Stock Market | Three major stock index futures were mixed, the US-Iran situation remains uncertain, and quantum computing concept stocks rose across the board before the market open.
Touyun Biotech (01332) has signed a strategic cooperation agreement with Shenzhen University to jointly develop the Chlorella Growth Factor project.
YIDA CHINA (03639) The contract sales amount in the first three months was approximately 0.37 billion yuan, a year-on-year decrease of 78.5%
Preview of US Stock Market | Three major stock index futures were mixed, the US-Iran situation remains uncertain, and quantum computing concept stocks rose across the board before the market open.
